Regulation of the expression of the transcription factor Mi in melanocytic cell lines and in melanoma patients.

The regulation of MITF (Microphthalmia-associated transcription factor) expression plays a fundamental role in the differentiation, survival, proliferation, and progression of melanocytic cells and melanoma. MITF acts as a master regulator of the melanocytic lineage by controlling the expression of genes involved in melanogenesis, cell proliferation, and survival. Its expression and activity are regulated by several signaling pathways, including MAPK/ERK, Wnt/β-catenin, PI3K/AKT, and cAMP, as well as by epigenetic mechanisms and lineage-specific transcription factors. Alterations in MITF levels or activity may contribute to the transformation of normal melanocytes and tumor progression, influencing processes such as proliferation, invasion, cellular plasticity, and treatment response. Investigating MITF regulation in melanocytic cell lines and melanoma patient samples may provide valuable insights into the molecular mechanisms underlying melanoma development and progression and may contribute to the identification of potential biomarkers and therapeutic targets.